Related Experiment Video
Updated: Aug 11, 2025

Murine Kidney Transplant Technique
Published on: October 20, 2015
Contrast-induced Nephropathy in Kidney Transplant Recipients: A Single-center Experience
Osama A Gheith1, Ayman M Nagib, Medhat A Halim
1The Nephrology Department, Hamed Al-Essa Organ Transplant Center, Sabah Area, Kuwait. ogheith@yahoo.com.
Insights
Contrast-induced nephropathy (CIN) affects kidney transplant (KT) recipients, with 7 of 79 patients developing it after contrast material (CM) use. Proactive risk assessment and management are crucial for these vulnerable patients.
Area of Science:
- Nephrology
- Transplant Medicine
- Radiology
Background:
- Kidney transplant (KT) recipients have unique risk factors for contrast-induced nephropathy (CIN), including immunosuppression and cardiovascular disease.
- Data on CIN in KT recipients is limited, necessitating further investigation.
Purpose of the Study:
- To determine the prevalence of CIN in KT recipients undergoing radiological assessment with low-osmolality iodine-based contrast material (CM).
Main Methods:
- A retrospective study of 3180 KT recipients from 2010-2020 identified 79 who received CM.
- Preventive measures were administered, and CIN was defined as a 25% serum creatinine increase within 72 hours.
Main Results:
- Seven (8.86%) of the 79 KT recipients developed CIN.
- The majority of patients had diabetic nephropathy as the cause of end-stage kidney disease.
- Graft function deteriorated in the CIN group, though no significant end-study difference was observed between groups.
Conclusions:
- CIN is a notable complication in KT recipients receiving CM, particularly those with ischemic heart disease.
- Risk stratification, hemodynamic optimization, and avoidance of nephrotoxins are vital before CM-enhanced procedures in KT recipients.
Introduction:
Data regarding contrast-induced nephropathy (CIN) in kidney transplant (KT) recipients are scarce despite the distinct risk factors such as the use of immunosuppressive agents, sympathetic denervation, glomerular hyperfiltration, and high prevalence of the cardiovascular disease. This study aimed to determine the prevalence of CIN in KT recipients who received low-osmolality iodine-based contrast material (CM) for radiological assessment.
Methods:
Between 2010 and 2020, 79 of the 3180 KT recipients followed at Hamed Al-Essa organ transplant center received low-osmolality iodine-based contrast for radiological assessment for various indications. Preventive measures including holding metformin, intravenous hydration, sodium bicarbonate and N-acetylcysteine were given before contrast administration. CIN was defined as an increase in serum creatinine of 25% from the baseline within 72 hours.
Results:
The enrolled patients were divided into two groups: those who developed CIN (n = 7) and those with no increase in serum creatinine level (n = 72). The mean age of the patients was 52.1 ± 12.3 years; 44 of them were males, and the cause of end-stage kidney disease was mostly diabetic nephropathy. The pre-transplant demographics were comparable between the two groups. Fortyseven cases received contrast for coronary angiography, and 32 received it for a CT scan. The graft function deteriorated in group 1, but no significant difference was found between the two groups at the end of the study.
Conclusion:
CIN is not uncommon in KT recipients receiving CM, especially with ischemic heart disease. Risk stratification, optimizing hemodynamics, and avoiding potential nephrotoxins are essential before performing CM-enhanced studies in KT recipients. DOI: 10.52547/ijkd.7165.
Related Concept Videos
Kidney Transplant I: Introduction
Kidney Transplant III: Nursing Management
Kidney Transplant II: Surgical Procedure
Acute Kidney Injury IV: Diagnostic Studies and Prevention
Acute Kidney Injury I: Introduction
Continuous Renal Replacement Therapy

